272 related articles for article (PubMed ID: 10813282)
1. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
3. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
4. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
7. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
8. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
9. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
10. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
Kohno N
J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
Kobayashi J; Itoh Y; Kitamura S; Kawai T
Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
13. [Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].
Harigai M
Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1985-9. PubMed ID: 14621589
[No Abstract] [Full Text] [Related]
14. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of KL-6 are positively correlated with those of CA15-3 in patients with interstitial pneumonia associated with collagen diseases.
Okada M; Suzuki K; Nakanishi T; Nakashima M
Respirology; 2006 Jul; 11(4):509-10. PubMed ID: 16771927
[No Abstract] [Full Text] [Related]
17. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
19. [Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia].
Kobayashi J; Tsukagoshi M; Hagiwara S; Kitamura S; Hirota N; Saito K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):837-42. PubMed ID: 8810769
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of interstitial pneumonia following surgery for lung cancer.
Takeda S; Maeda H; Sawabata N; Kitada S; Mori M; Takashima S; Matsubara Y
Thorac Cardiovasc Surg; 2006 Jun; 54(4):268-72. PubMed ID: 16755450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]